New patch could ease agitation for Alzheimer's patients

NCT ID NCT06052254

Recruiting now Symptom relief Sponsor: Teikoku Pharma USA, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 2 times

Summary

This study tests a medicated skin patch (dexmedetomidine) to see if it can reduce agitation in people with Alzheimer's dementia. About 150 adults living in care facilities will receive either the patch or a placebo for 96 hours. The goal is to measure changes in agitated behavior using a standard scale.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGITATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease dementia Psychomotor Agitation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AGITATION

Contacts and locations

Locations

Arrow Clinical Trials
RECRUITING

Daytona Beach, Florida, 32117, United States
BioBehavioral Health
WITHDRAWN

Toms River, New Jersey, 08755, United States
Elixia MA, LLC
WITHDRAWN

Springfield, Massachusetts, 01103, United States
Global Medical Institutes Florida LLC
RECRUITING

Miami, Florida, 33125, United States
Miami Jewish Health
RECRUITING

Miami, Florida, 33137, United States
Personal Physician Care
RECRUITING

Delray Beach, Florida, 33445, United States
Professional Health Care of Pinellas, LLC
RECRUITING

St. Petersburg, Florida, 33713, United States
Vitalix
RECRUITING

Worcester, Massachusetts, 01608, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.